GS-4774

N/A

Report date: 2023/05/30 20:00:25

Base Information

Drug NameGS-4774

Drug Alias NameInactivated recombinant Saccharomyces cerevisiae expressing Hepatitis B virus XGI-13020X-S-CoreX-ScoreGS-4774

ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHepatitis B, Chronic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited StatesRomania +[6]

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGlobeimmune Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsHepatitis B, Chronic

ATC CodeN/A